Should You Buy Evolent Health, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Evolent Health, Inc. (EVH) carries a solid Quality of Company rating of 5.9/10. Trading at $3.74, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 5 of 6 CirclFi valuation models project upside for Evolent Health, Inc. (EVH) at $3.74 — the model consensus leans bullish, with a Quality Score of 5.9/10 and Value-Trap risk of 31/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Evolent Health, Inc. (EVH) in 2026?
What Is the Bull Case vs the Bear Case for Evolent Health, Inc. (EVH)?
| Bull case — $17.20 target (+360.0%) | Bear case — $2.63 target (-29.7%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $3.74 and the median fair value of $9.98 implies +166.9% upside potential. | According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model sees the stock as overvalued with a fair value of $2.63 (-29.7%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $17.20 (+360.0%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +389.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
How Does EVH Compare to Its Health Information Services Peers?
Valuation data pages: SOPH · OMDA · PBSV · AMWL · DRIO · CTEV · RVRC · PHR · NRC · DOCS · HQY
Which Other Stocks Score Like EVH on Quality?
Closest companies to EVH’s Quality of Company score of 5.9/10, across all industries.
- CABR — Caring Brands, Inc. (QOC 5.9) · analysis
- APSI — Aqua Power Systems Inc. (QOC 5.9) · analysis
- ANDG — Andersen Group Inc. (QOC 5.9) · analysis
- TOP — TOP Financial Group Limited (QOC 5.9) · analysis
- BOLT — Bolt Biotherapeutics, Inc. (QOC 5.9) · analysis
- RPAY — Repay Holdings Corporation (QOC 5.9) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Health Information Services Screens Does EVH Appear In?
So Is Evolent Health, Inc. (EVH) Worth Buying in 2026?
Evolent Health, Inc. at $3.74 presents what our engine identifies as a high-conviction opportunity: 5 of 6 models see upside, quality stands at 5.9/10, and the median fair value of $9.98 implies +166.9% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Evolent Health, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About EVH Stock?
Should I buy EVH stock right now?
Based on CirclFi's multi-model analysis, 5 of 6 models see upside for EVH at $3.74. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 5.9/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Evolent Health, Inc.?
Key risks include: limited model coverage (6/13 active), reducing analytical confidence; wide model disagreement (554% spread), signaling high uncertainty; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.
How does EVH compare to its competitors?
Among Health Information Services peers, EVH holds a Quality Score of 5.9/10. Comparable companies include SOPH (QOC 5.9), OMDA (QOC 5.8), PBSV (QOC 5.9). The relative ranking helps investors identify whether EVH offers better fundamental quality than alternatives in the same sector.
Is EVH a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. EVH's Quality Score of 5.9/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy EVH at?
CirclFi does not provide target buy prices or price alerts. However, our 6 active models produce fair value estimates ranging from $2.63 to $17.20. At $3.74, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for EVH.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad